Yu. I. Ragino

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons et al. · The Lancet · 2021 · 285 citations · Full text

Family Medicine, Metabolic Syndrome, Lipid Disorder +10

Disorders of lipid metabolism. Clinical Guidelines 2023

G. Arabidze, Aronov Dm, G. P. Arutyunov et al. · Russian Journal of Cardiology · 2023 · 174 citations · Full text

Family Medicine, Metabolic Disorder, Hyperlipidemia +16

Hypertension in the Russian population during the COVID-19 pandemic: sex differences in prevalence, treatment and its effectiveness. Data from the ESSE-RF3 study

Yu. А. Balanova, А. V. Kontsevaya, M. B. Kotova et al. · CARDIOVASCULAR THERAPY AND PREVENTION · 2023 · 46 citations · Full text

Hypertension, Pressure Measurement, Covid-19 Epidemiology +19

EURASIAN ASSOCIATION OF CARDIOLOGY (EAC)/ RUSSIAN NATIONAL ATHEROSCLEROSIS SOCIETY (RNAS, RUSSIA) GUIDELINES FOR THE DIAGNOSIS AND CORRECTION OF DYSLIPIDEMIA FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS (2020)

I. V. Sergienko, G. Arabidze, P. A. Zelveyan et al. · Eurasian heart journal · 2020 · 43 citations · Full text

Cardiometabolic Risk, Evidence-based Medicine, Clinical Specialties +32

Prevalence of coronary heart disease (by epidemiological criteria) and its association with lipid and non-lipid risk factors in the Novosibirsk population of 25-45 years

Yu. I. Ragino, N. A. Kuzminykh · Russian Journal of Cardiology · 2019 · 40 citations · Full text

Hypertension, Cardiometabolic Risk, Relative Risk +22